Cynthia W Karlson, Nicole M Alberts, Wei Liu, Tara M Brinkman, Robert D Annett, Daniel A Mulrooney, Fiona Schulte, Wendy M Leisenring, Todd M Gibson, Rebecca M Howell, Deokumar Srivastava, Kevin C Oeffinger, Leslie L Robison, Gregory T Armstrong, Lonnie K Zeltzer, Kevin R Krull
BACKGROUND: The objective of this study was to characterize the prevalence and risk of pain, pain interference, and recurrent pain in adult survivors of childhood cancer in comparison with siblings. METHODS: This study analyzed longitudinal data from survivors (n = 10,012; 48.7% female; median age, 31 years [range, 17-57 years]; median time since diagnosis, 23 years) and siblings (n = 3173) from the Childhood Cancer Survivor Study. Survivors were diagnosed between 1970 and 1986 at 1 of 26 participating sites...
March 30, 2020: Cancer
Nicole L Stout, Justin C Brown, Anna L Schwartz, Timothy F Marshall, Anna M Campbell, Larissa Nekhlyudov, David S Zucker, Karen M Basen-Engquist, Grace Campbell, Jeffrey Meyerhardt, Andrea L Cheville, Kelley R Covington, Jennifer A Ligibel, Jonas M Sokolof, Kathryn H Schmitz, Catherine M Alfano
No abstract text is available yet for this article.
March 25, 2020: Cancer
Rowan T Chlebowski, Aaron K Aragaki, Garnet L Anderson, Ross L Prentice
After reports from the Women's Health Initiative randomized trial evaluating estrogen plus progestin, there was a sudden, substantial, and sustained decrease in all categories of menopausal hormone therapy, and the first reduction in age-adjusted breast cancer incidence in more than 20 years was seen in 2003-2004 among US women 50 years of age or older. Subsequent trends in breast cancer incidence have been described, but most reports have not focused on the postmenopausal age group or fully engaged the potential influence of reduced hormone therapy on breast cancer incidence trends by race/ethnicity...
March 25, 2020: Cancer
Nicole H Dalal, Fumiko Chino, Hannah Williamson, Georgia M Beasley, April K S Salama, Manisha Palta
BACKGROUND: Investigating scientific publication trends in the field of oncology may highlight opportunities for improved representation, mentorship, collaboration, and advancement for women. METHODS: We conducted a bibliometric analysis of Annals of Surgical Oncology; Cancer; International Journal of Radiation Oncology, Biology, Physics (IJROBP); JAMA Oncology; and Journal of Clinical Oncology in 1990, 2000, 2010, and 2017. Full name and degree credentials per author role (ie, first or senior author), article type, publication year, and citation metrics were collected...
March 25, 2020: Cancer
Narjust Duma
No abstract text is available yet for this article.
March 25, 2020: Cancer
Chelsea K Osterman, Matthew I Milowsky
No abstract text is available yet for this article.
March 24, 2020: Cancer
Sumanta K Pal, Dean Bajorin, Nazli Dizman, Jean Hoffman-Censits, David I Quinn, Daniel P Petrylak, Matthew D Galsky, Ulka Vaishampayan, Ugo De Giorgi, Sumati Gupta, Howard A Burris, Harris S Soifer, Gary Li, Hao Wang, Carl L Dambkowski, Susan Moran, Siamak Daneshmand, Jonathan E Rosenberg
BACKGROUND: Infigratinib (BGJ398) is a potent and selective fibroblast grown factor receptor 1 to 3 (FGFR1-3) inhibitor with significant activity in patients with advanced or metastatic urothelial carcinoma bearing FGFR3 alterations. Given the distinct biologic characteristics of upper tract urothelial carcinoma (UTUC) and urothelial carcinoma of the bladder (UCB), the authors examined whether infigratinib had varying activity in these settings. METHODS: Eligible patients had metastatic urothelial carcinoma with activating FGFR3 mutations and/or fusions...
March 24, 2020: Cancer
Zhenqiu Liu, Chen Suo, Xianhua Mao, Yanfeng Jiang, Li Jin, Tiejun Zhang, Xingdong Chen
BACKGROUND: The incidence of primary liver cancer (PLC) continues to increase worldwide. The incidence trends and patterns of PLC associated with different age at diagnosis remain unknown. METHODS: We collected detailed information on PLC between 1990 and 2017 from Global Burden of Disease Study 2017. Estimated annual percentage changes in the PLC age-standardized incidence rate (ASR) diagnosed by age, sex, region, and etiology were calculated to quantify the temporal trends in PLC ASR...
March 23, 2020: Cancer
Steven I Hajdu
During the period from 1922 to 1942, several carcinogens were identified in coal tar, industrial oils, and petroleum, and radium was added to x-ray as a potential carcinogen. It was proven that some viruses are capable of causing cancer, and the dependency of prostatic and mammary hyperplasia and carcinoma on naturally occurring hormones was established. Colon cancer was linked to hereditary and nonhereditary polyposis. A permanent place for diagnostic radiology was defined and radiation therapy advanced to preoperative and postoperative modalities using x-ray and radium...
March 20, 2020: Cancer
Chenghui Li, Marie-Rachelle Narcisse, Pearl A McElfish
BACKGROUND: Although medical financial hardship (MFH) resulting from sequelae of cancer and treatment has been reported in other racial/ethnic populations, little is known about MFH among Native Hawaiian and Pacific Islander (NHPI) cancer survivors. METHODS: One hundred fifty adult NHPI cancer survivors were identified from the 2014 NHPI National Health Interview Survey (NHIS). Cancer survivors were those with a history of cancer (excluding nonmelanoma/unknown type of skin cancer)...
March 20, 2020: Cancer
Mariano Russo, Jordan M Newell, Laura Budurlean, Kenneth R Houser, Kathryn Sheldon, Joshua Kesterson, Rebecca Phaeton, Carrie Hossler, Jennifer Rosenberg, David DeGraff, Lauren Shuman, James R Broach, Joshua I Warrick
BACKGROUND: Endometrial hyperplasia is a precursor to endometrioid adenocarcinoma (EMC), the most common uterine cancer. The likelihood of progression to carcinoma may be evaluated by histologic subclassification of endometrial hyperplasia, although these subclasses are subjective and only modestly reproducible among pathologists. Patient care would be improved by a more objective test to predict the risk of cancer progression. METHODS: Next-generation sequencing was performed on archived endometrial biopsy specimens from a retrospective cohort of women with endometrial hyperplasia...
March 18, 2020: Cancer
Justin M Barnes, Kimberly J Johnson, Eric Adjei Boakye, Rosh K V Sethi, Mark A Varvares, Nosayaba Osazuwa-Peters
BACKGROUND: Cost-related medication underuse (CRMU), a measure of access to care and financial burden, is prevalent among cancer survivors. The authors quantified the impact of the Patient Protection and Affordable Care Act (ACA) on CRMU in nonelderly cancer survivors. METHODS: Using National Health Interview Survey data (2011-2017) for cancer survivors aged 18 to 74 years, the authors estimated changes in CRMU (defined as taking medication less than prescribed due to costs) before (2011-2013) to after (2015-2017) implementation of the ACA...
March 18, 2020: Cancer
Salma Shariff-Marco, Scarlett Lin Gomez, Alison J Canchola, Hannah Fullington, Amy E Hughes, Hong Zhu, Sandi L Pruitt
BACKGROUND: Among Latinas with breast cancer, residence in an ethnic enclave may be associated with survival. However, findings from prior studies are inconsistent. METHODS: The authors conducted parallel analyses of California and Texas cancer registry data for adult (aged ≥18 years) Latinas who were diagnosed with invasive breast cancer from 1996 to 2005, with follow-up through 2014. Existing indices applied to tract-level 2000 US Census data were used to measure Latinx enclaves and neighborhood socioeconomic status (nSES)...
March 17, 2020: Cancer
Damon R Reed, Jonathan Metts, Mariyah Pressley, Brooke L Fridley, Masanori Hayashi, Michael S Isakoff, David M Loeb, Rikesh Makanji, Ryan D Roberts, Matteo Trucco, Lars M Wagner, Mark G Alexandrow, Robert A Gatenby, Joel S Brown
No abstract text is available yet for this article.
March 16, 2020: Cancer
Philipp Karschnia, Tracy T Batchelor, Justin T Jordan, Brian Shaw, Sebastian F Winter, Frank J Barbiero, Leon D Kaulen, Niklas Thon, Joerg-Christian Tonn, Anita J Huttner, Robert K Fulbright, Jay Loeffler, Jorg Dietrich, Joachim M Baehring
BACKGROUND: Clinical experience is limited for primary central nervous system (CNS) lymphoma that arises from the dura mater, which is denoted with the term primary dural lymphoma (PDL). This study was aimed at determining the relative incidence, presentation, and outcomes of PDL. METHODS: The institutional databases of the Divisions of Neuro-Oncology at the Massachusetts General Hospital and the Yale School of Medicine were retrospectively searched for patients with primary CNS lymphoma...
March 16, 2020: Cancer
Richard A Newcomb, Ryan D Nipp, Lauren P Waldman, Joseph A Greer, Daniel E Lage, Ephraim P Hochberg, Vicki A Jackson, Charn-Xin Fuh, David P Ryan, Jennifer S Temel, Areej R El-Jawahri
BACKGROUND: Inpatient supportive care programs often target patients with advanced solid tumors. To the authors' knowledge, few studies to date have characterized symptom burden in hospitalized patients with potentially curable cancers. The objective of the current study was to compare symptom burden, palliative care consultation, and readmission rates in hospitalized patients by cancer type and treatment intent. METHODS: The authors conducted a single-center study of hospitalized patients with cancer between 2014 and 2017...
March 13, 2020: Cancer
James R Broughman, David D Xiong, Benjamin J Moeller, Kevin J Contrera, Brandon L Prendes, Eric D Lamarre, Jamie A Ku, Brian B Burkey, Neil M Woody, Nikhil P Joshi, David J Adelstein, Jessica L Geiger, Catherine H Frenkel, Zvonimir L Milas, Daniel S Brickman, Ashley L Sumrall, Daniel R Carrizosa, John F Greskovich, Shlomo A Koyfman, Matthew C Ward
BACKGROUND: De-intensified treatment strategies for early human papillomavirus-positive (HPV+) oropharynx cancer (OPC) rely on selecting patients with an excellent prognosis. The criterion for enrollment in current de-intensification trials is ≤10 pack-years. More nuance to the pack-year criteria may expand enrollment, improve patient outcomes, and prevent overtreatment. It was hypothesized that patients with more than 10 pack-years may experience favorable outcomes if smoking cessation has been achieved...
March 13, 2020: Cancer
Lin Kong, Jinsong Wu, Jing Gao, Xianxin Qiu, Jing Yang, Jiyi Hu, Weixu Hu, Ying Mao, Jiade J Lu
BACKGROUND: The objective of this study was to evaluate the outcomes of patients with high-grade glioma who received treatment with particle radiotherapy. METHODS: Between June 2015 and October 2018, 50 consecutive and nonselected patients with glioblastoma multiforme (n = 34) or anaplastic glioma (n = 16) were treated at the Shanghai Proton and Heavy Ion Center. Twenty-four patients received proton radiotherapy (at a dose of 60 gray-equivalents in 30 daily fractions), and 26 patients received proton radiotherapy plus a carbon-ion radiotherapy (CIRT) boost in various dose-escalating schemes...
March 13, 2020: Cancer
S Jane Henley, Elizabeth M Ward, Susan Scott, Jiemin Ma, Robert N Anderson, Albert U Firth, Cheryll C Thomas, Farhad Islami, Hannah K Weir, Denise Riedel Lewis, Recinda L Sherman, Manxia Wu, Vicki B Benard, Lisa C Richardson, Ahmedin Jemal, Kathleen Cronin, Betsy A Kohler
BACKGROUND: The American Cancer Society, the Centers for Disease Control and Prevention, the National Cancer Institute, and the North American Association of Central Cancer Registries collaborate to provide annual updates on cancer occurrence and trends in the United States. METHODS: Data on new cancer diagnoses during 2001 through 2016 were obtained from the Centers for Disease Control and Prevention-funded and National Cancer Institute-funded population-based cancer registry programs and compiled by the North American Association of Central Cancer Registries...
March 12, 2020: Cancer
S Jane Henley, Cheryll C Thomas, Denise Riedel Lewis, Elizabeth M Ward, Farhad Islami, Manxia Wu, Hannah K Weir, Susan Scott, Recinda L Sherman, Jiemin Ma, Betsy A Kohler, Kathleen Cronin, Ahmedin Jemal, Vicki B Benard, Lisa C Richardson
BACKGROUND: The Centers for Disease Control and Prevention, the American Cancer Society, the National Cancer Institute, and the North American Association of Central Cancer Registries collaborate to provide annual updates on cancer occurrence and trends in the United States and to address a special topic of interest. Part I of this report focuses on national cancer statistics, and part 2 characterizes progress in achieving select Healthy People 2020 cancer objectives. METHODS: For this report, the authors selected objectives-including death rates, cancer screening, and major risk factors-related to 4 common cancers (lung, colorectal, female breast, and prostate)...
March 12, 2020: Cancer
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"